Skip to content
healthcare.dev

Carbinoxamine Maleate

NDC 44523-825, Carbinoxamine Maleate, tablet, from Biocomp Pharma, Inc..

Product NDC
44523-825
Status
Listed
Labeler
Biocomp Pharma, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090756
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44523-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBINOXAMINE MALEATE4 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
44523-825-01445230825011 BOTTLE in 1 CARTON (44523-825-01) / 100 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/14266e97-674b-b6a9-37a2-a955f0a01c4f
  • NADAC price for package 44523082501

    GET /v1/drugs/nadac/44523082501

Use it

Look up 44523-825 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44523-825 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44523-825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.